Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 23;8(3):38.
doi: 10.3390/ijns8030038.

Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United States

Marci K Sontag  1   2 , Joshua I Miller  1 , Sarah McKasson  1 , Amy Gaviglio  3 , Stacey L Martiniano  4   5 , Rhonda West  1 , Marisol Vazquez  6   7 , Clement L Ren  8   9 , Philip M Farrell  10 , Susanna A McColley  6   7 , Yvonne Kellar-Guenther  1   2
Affiliations

Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United States

Marci K Sontag et al. Int J Neonatal Screen. .

Abstract

Cystic fibrosis (CF) newborn screening (NBS) was universally adopted in 2009 in the United States. Variations in NBS practices between states may impact the timing of diagnosis and intervention. Quantitative metrics can provide insight into NBS programs (NBSP), but the nuances cannot be elucidated without additional feedback from programs. This study was designed to determine facilitators and barriers to timely diagnosis and intervention following NBS for CF. The median age at the first CF event for infants with CF within each state was used to define early and late states (n = 15 per group); multiple CF centers were invited in states with more than two CF centers. Thirty states were eligible, and 61 NBSP and CF centers were invited to participate in structured interviews to determine facilitators and barriers. Once saturation of themes was reached, no other interviews were conducted. Forty-five interviews were conducted (n = 16 early CF center, n = 12 late CF center, n = 11 early NBSP, and n = 6 late NBSP). Most interviewees reported good communication between CF centers and NBSP. Communication between primary care providers (PCPs) and families was identified as a challenge, leading to delays in referral and subsequent diagnosis. The misperception of low clinical risk in infants from racial and ethnic minority groups was a barrier to early diagnostic evaluation for all groups. NBSP and CF centers have strong relationships. Early diagnosis may be facilitated through more engagement with PCPs. Quality improvement initiatives should focus on continuing strong partnerships between CF centers and NBS programs, improving education, communication strategies, and partnerships with PCPs, and improving CF NBS timeliness and accuracy.

Keywords: cystic fibrosis; diagnosis; newborn screening; primary care providers; qualitative; timeliness.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Comeau A.M., Parad R.B., Dorkin H.L., Dovey M., Gerstle R., Haver K., Lapey A., O’Sullivan B.P., Waltz D.A., Zwerdling R.G., et al. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: A cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics. 2004;113:1573–1581. doi: 10.1542/peds.113.6.1573. - DOI - PubMed
    1. Rock M.J., Hoffman G., Laessig R.H., Kopish G.J., Litsheim T.J., Farrell P.M. Newborn screening for cystic fibrosis in Wisconsin: Nine-year experience with routine trypsinogen/DNA testing. J. Pediatr. 2005;147:S73–S77. doi: 10.1016/j.jpeds.2005.08.004. - DOI - PubMed
    1. Wilcken B., Wiley V., Sherry G., Bayliss U. Neonatal screening for cystic fibrosis: A comparison of two strategies for case detection in 1.2 million babies. J. Pediatr. 1995;127:965–970. doi: 10.1016/S0022-3476(95)70040-4. - DOI - PubMed
    1. Kharrazi M., Yang J., Bishop T., Lessing S., Young S., Graham S., Pearl M., Chow H., Ho T., Currier R., et al. Newborn Screening for Cystic Fibrosis in California. Pediatrics. 2015;136:1062–1072. doi: 10.1542/peds.2015-0811. - DOI - PubMed
    1. Kloosterboer M., Hoffman G., Rock M., Gershan W., Laxova A., Li Z., Farrell P.M. Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen. Pediatrics. 2009;123:e338–e346. doi: 10.1542/peds.2008-1681. - DOI - PubMed

LinkOut - more resources